In addition, because the biological behaviors of ovarian cancer cells can be modulated by miR-203a-3p through its effects on the Akt/GSK-3β/Snail signaling pathway via ATM, miR-203a-3p upregulation is expected to provide a beneficial strategy for the clinical treatment of ovarian cancer. This evidence concerns the gene GSK3B and ovarian carcinoma.